Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Pharmacokinetic and safety of raltegravir in pregnancy.

Croci L, Trezzi M, Allegri MP, Carli T, Chigiotti S, Riccardi MP, Ricciardi B, Toti M, Nencioni C.

Eur J Clin Pharmacol. 2012 Aug;68(8):1231-2. doi: 10.1007/s00228-012-1250-5. Epub 2012 Mar 1. No abstract available.

PMID:
22382989
2.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Spanish.

PMID:
22633764
3.

The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.

Scarsi KK, Postelnick MJ.

J Gend Specif Med. 2003;6(1):7-16. Review. No abstract available.

PMID:
12661172
4.

[Antiretroviral therapy and prevention of maternal-fetal transmission of HIV-1. Current and future strategies].

Monpoux F, Bongain A, BĂ©rard E, Gillet JY.

Arch Pediatr. 1999 May;6(5):556-65. Review. French.

PMID:
10370814
5.

Management of HIV infection during pregnancy.

McGowan JP, Shah SS.

Curr Opin Obstet Gynecol. 2000 Oct;12(5):357-67. Review.

PMID:
11111877
6.

[Vertical HIV-I-transmission. I. Risk and prevention in pregnancy].

Orendi JM, Boer K, van Loon AM, Borleffs JC, van Oppen AC, Boucher CA.

Ned Tijdschr Geneeskd. 1998 Dec 12;142(50):2720-4. Review. Dutch.

PMID:
10065235
7.

Zidovudine.

Sperling R.

Infect Dis Obstet Gynecol. 1998;6(5):197-203. Review.

8.

[Progress in the study of maternal-fetal vertical transmission of human immunodeficiency virus type-1].

Wu X, Li DJ.

Zhonghua Fu Chan Ke Za Zhi. 2004 Jun;39(6):419-22. Review. Chinese. No abstract available.

PMID:
15312331
9.

Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).

Pujari S, Patel A, Joshi SR, Gangakhedkar R, Kumarasamy N, Gupta SB; Expert Panel 2008.

J Assoc Physicians India. 2008 May;56:339-48, 353-71. Review. No abstract available.

PMID:
18700643
10.

Use of antiretroviral drugs to prevent sexual transmission of HIV.

Cohen MS, Hosseinipour M, Kashuba A, Butera S.

Curr Clin Top Infect Dis. 2002;22:214-51. Review. No abstract available.

PMID:
12520656
11.

Raltegravir, an HIV-1 integrase inhibitor for HIV infection.

Cabrera C.

Curr Opin Investig Drugs. 2008 Aug;9(8):885-98. Review.

PMID:
18666037
12.

Role of raltegravir in HIV-1 management.

Rokas KE, Bookstaver PB, Shamroe CL, Sutton SS, Millisor VE, Bryant JE, Weissman SB.

Ann Pharmacother. 2012 Apr;46(4):578-89. doi: 10.1345/aph.1Q616. Epub 2012 Apr 10. Review.

PMID:
22496475
13.

Prevention of vertical transmission of HIV-1 in resource-limited settings.

Coutsoudis A, Kwaan L, Thomson M.

Expert Rev Anti Infect Ther. 2010 Oct;8(10):1163-75. doi: 10.1586/eri.10.94. Review.

PMID:
20954881
14.
15.

Prevention of perinatal HIV transmission during pregnancy.

McGowan JP, Shah SS.

J Antimicrob Chemother. 2000 Nov;46(5):657-68. Review.

PMID:
11062184
16.

Treatment of HIV infection with raltegravir.

Chirch LM, Morrison S, Steigbigel RT.

Expert Opin Pharmacother. 2009 May;10(7):1203-11. doi: 10.1517/14656560902911488 . Review.

PMID:
19385721
17.

Prevention of pediatric human immunodeficiency virus.

Wilfert CM, Stringer JS.

Semin Pediatr Infect Dis. 2004 Jul;15(3):190-8. Review. No abstract available.

PMID:
15480965
18.

Drug reaction with eosinophilia and systemic symptoms associated with raltegravir use: case report and review of the literature.

Ripamonti D, Benatti SV, Di Filippo E, Ravasio V, Rizzi M.

AIDS. 2014 Apr 24;28(7):1077-9. doi: 10.1097/QAD.0000000000000204. Review. No abstract available.

PMID:
24685746

Supplemental Content

Support Center